Nephrol Dial Transplant (2003) 18: 631-640
© 2003 European Renal Association-European Dialysis and Transplant Association
Fernando Valderrabano Memorial Lecture
Why is coronary heart disease of uraemic patients so frequent and so devastating?
1 Department of Pathology University of Erlangen–Nürnberg, 2 Department of Internal Medicine, University of Heidelberg, Germany and 3 Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian University School of Medicine, Katowice, Poland
Abstract
On September 6, 2001, Professor Fernando Valderrabano (Hospital Gregorio Marañon, Madrid) died at the age of 59 years. He was a leading figure in Spanish nephrology, a full professor of Medicine/Nephrology at the University Complutense of Madrid, and an outstanding scientist who published more than 300 articles in medical journals. He was a very intelligent and cultured person, and a man of great style who enjoyed a wide range of hobbies and interests in addition to his medical work. All his colleagues and friends mourn his passing.
Notes
Correspondence and offprint requests to: Professor K. Amann, Department of Internal Medicine, University of Heidelberg, Bergheimer Strasse 58, D-69115 Heidelberg, Germany. Email: kerstin.amann{at}patho.imed.uni-erlangen.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Rabkin, I. Awwad, Y. Chen, E. A. Ashley, D. Sun, S. Sood, W. Clusin, P. Heidenreich, G. Piecha, and M.-L. Gross Low-Dose Growth Hormone is Cardioprotective in Uremia J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1774 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hocher, L. Liefeldt, T. Quaschning, P. Kalk, R. Ziebig, M. Godes, K. Relle, G. Asmus, and J.-P. Stasch Soluble CD154 Is a Unique Predictor of Nonfatal and Fatal Atherothrombotic Events in Patients Who Have End-Stage Renal Disease and Are on Hemodialysis J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1323 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Meier, F. Spertini, E. Blanc, and M. Burnier Oxidized Low-Density Lipoproteins Activate CD4+ T Cell Apoptosis in Patients with End-Stage Renal Disease through Fas Engagement J. Am. Soc. Nephrol., January 1, 2007; 18(1): 331 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.H. Messerli, G. Mancia, C.R. Conti, A.C. Hewkin, S. Kupfer, A. Champion, R. Kolloch, A. Benetos, C.J. Pepine, K. Nakagawa, et al. Lowering of Blood Pressure--The Lower, the Better?: Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884-893, 2006 J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2345 - 2352. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yildiz, E. Memisoglu, H. Oflaz, H. Yazici, H. Pusuroglu, V. Akkaya, F. Erzengin, and S. Tepe Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients Nephrol. Dial. Transplant., April 1, 2005; 20(4): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dikow, L. P. Kihm, M. Zeier, J. Kapitza, J. Tornig, K. Amann, C. Tiefenbacher, and E. Ritz Increased Infarct Size in Uremic Rats: Reduced Ischemia Tolerance? J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1530 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Koomans, P. J. Blankestijn, and J. A. Joles Sympathetic Hyperactivity in Chronic Renal Failure: A Wake-up Call J. Am. Soc. Nephrol., March 1, 2004; 15(3): 524 - 537. [Abstract] [Full Text] [PDF]
|
|